Table 3.
Primary inpatient outcomes, inpatient mortality, and resource utilization
| Outcome | Non-GI cancer | Esophageal cancer | aOR (95% CI)/beta coefficient (95% CI) |
Gastric cancer | aOR (95% CI)/beta coefficient (95% CI) |
Hepatic cancer | aOR (95% CI)/beta coefficient (95% CI) |
Cholangio-carcinoma | aOR (95% CI)/beta coefficient (95% CI) |
Pancreatic cancer | aOR (95% CI)/beta coefficient (95% CI) |
Colon cancer | aOR (95% CI)/beta coefficient (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients, n | 34,365 | 39 | 74 | 1,612 | 75 | 927 | 497 | ||||||
|
| |||||||||||||
| Inpatient mortality | 745 (2.1%) | 0 | na | 9 (12.1%) |
8.6 (1.8–39.7) |
123 (7.6%) |
2.77 (1.5–4.8) |
5 (6.7%) |
1.86 (0.4–7) |
39 (4.2%) |
1.25 (0.4–3.6) |
10 (2%) |
0.56 (0.06–4.6) |
|
| |||||||||||||
| Mean total hospitalization charges (±SD; US$) | 54,418± 1,741 | 28,017± 3,510 | −22,508 (−44,931 to −84) | 36,995± 11,410 | −9,700 (−34,908 to 15,507) | 45,317± 2,957 | −10,332 (−16,964 to −3,701) | 24,114± 3,883 | −22,463 (−49,563 to −4,690) | 69,109± 22,347 | 21,843 (−26,724 to 70,410) | 42,423± 5,658 | −15,646 (−26,194 to −5,098) |
|
| |||||||||||||
| Mean length of stay (±SD; in days) | 5.78± 0.08 | 4.78 (±0.74) | −0.37 (−1.58 to 0.84) | 4.81 (±0.93) |
−0.2 (−1.32 to 0.92) |
5.1 (±0.22) |
−0.61 (−0.95 to −0.26) | 3.56 (± 0.59) |
−1.27 (−2.38 to −0.16) | 5.37 (±0.45) | 0.22 (−0.55 to 1.00) |
5.69 (±0.46) | 0.004 (−0.57 to 0.58) |
aOR along with 95% confidence intervals has been reported for inpatient mortality. Beta-coefficient along with 95% confidence intervals has been reported for the outcomes of total hospitalization charges and length of stay. aOR, adjusted odds ratio.